These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 21254949

  • 21. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G.
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [Abstract] [Full Text] [Related]

  • 22. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG, Gloekler S, Levy BI, Skalidis E, Tagliamonte E, Vardas P, Heusch G.
    Int J Cardiol; 2016 Jul 15; 215():1-6. PubMed ID: 27104917
    [Abstract] [Full Text] [Related]

  • 23. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
    Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS.
    Am J Med; 2015 Mar 15; 128(3):219-28. PubMed ID: 25447617
    [Abstract] [Full Text] [Related]

  • 24. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A, de Silva R.
    Cardiovasc Drugs Ther; 2016 Aug 01; 30(4):407-417. PubMed ID: 27475447
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease.
    Vilaine JP.
    Pharmacol Res; 2006 May 01; 53(5):424-34. PubMed ID: 16638639
    [Abstract] [Full Text] [Related]

  • 30. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R, Ceconi C.
    Expert Rev Cardiovasc Ther; 2011 Aug 01; 9(8):959-73. PubMed ID: 21878041
    [Abstract] [Full Text] [Related]

  • 31. Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.
    Porres-Aguilar M, Muñoz OC, Abbas A.
    Curr Cardiol Rep; 2016 Feb 01; 18(2):13. PubMed ID: 26768739
    [Abstract] [Full Text] [Related]

  • 32. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
    Reil JC, Reil GH, Böhm M.
    Trends Cardiovasc Med; 2009 Jul 29; 19(5):152-7. PubMed ID: 20005474
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
    López-Bescós L, Filipova S, Martos R.
    Cardiology; 2007 Jul 29; 108(4):387-96. PubMed ID: 17890862
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.